vivo in Biological Technology

The IN VIVO Blog Selects First Annual 'Deal of the Year'

NORWALK, Conn., Jan. 8 /PRNewswire/ -- The readers of The IN VIVO Blog , which provides news, insights and analysis on the biopharmaceutical and medical device industries, have selected a Deal of the Year for 2008 -- Alnylam Pharmaceuticals' RNA interference alliance with Takeda Pharmaceutical...

Sigma-Aldrich Introduces MISSION(R) In VIVO QUALITY and iScale Oligos(TM) siRNA, a Superior Quality siRNA Designed for RNAi Research in Animal Models

ST. LOUIS, Nov. 20 /PRNewswire-FirstCall/ -- Sigma-Aldrich (Nasdaq: SIAL ) announced today the global release of MISSION(R) In VIVO QUALITY and iScale Oligos(TM) siRNA. MISSION(R) In VIVO QUALITY and iScale Oligos(TM) siRNA are expected to allow researchers to successfully take the next step in ...

Altogen Biosystems Launches New Nanoparticle-based In Vivo Transfection Reagent

LAS VEGAS, Nov. 3 /PRNewswire/ -- Altogen Biosystems (http://www.altogen.com ) announced launch of novel Nanoparticle-based transfection reagent for use in laboratories and research facilities for animal testing. Transfection is one of the major laboratory methods used to introduce DNA and RN...

LI-COR August 27th On-Line Webinar Introduces New Approach to Small Animal In Vivo Imaging

LINCOLN, Neb., Aug. 20 /PRNewswire/ -- LI-COR announces its second webinar in its training and education series. The 30-minute seminar, Advances in In Vivo Imaging: Near Infrared Optical Imaging of Mice, will be held on August 27th at 11:00 a.m. CDT. Near-infrared (NIR) fluorescence offers d...

First Live U.S. Demonstration of Cellvizio GI In Vivo Cellular Imaging Technology to Occur at Johns Hopkins Conference

PHILADELPHIA, March 5 /PRNewswire/ -- Cellvizio Inc., a leader in in vivo cellular imaging, announced today that the first live U.S. demonstration of its Cellvizio(R) GI technology will be conducted March 10, 2008, during the Johns Hopkins University School of Medicine's Eighth Annual Gastroen...

Chris Tihansky Appointed President of In Vivo Cellular Imaging Leader Cellvizio Inc.

- Company Establishes U.S. subsidiary in Philadelphia Area - PHILADELPHIA, Feb. 13 /PRNewswire/ -- Cellvizio Inc., a leader in in vivo cellular imaging, announced today the appointment of Chris Tihansky as its President. Cellvizio Inc. is the U.S. subsidiary of Paris-based Mauna Kea Tech...

In vivo visualization of alternative splicing

The February 1 cover of G&D features an unprecedented use of fluorescent proteins to visualize developmentally regulated alternative mRNA splicing in a living organism. Dr. Hidehito Kuroyanagi and colleagues at the Tokyo Medical and Dental University engineered a transgenic alternative splicing re...

CRi Announces Maestro 2, the Next Generation in Vivo Optical Imaging Systems

WOBURN, Mass., Nov. 26 /PRNewswire/ -- Cambridge Research & Instrumentation, Inc. (CRi) announces the launch of Maestro 2 optical imaging systems in North America. The Maestro 2 received widespread acclaim at the both the recent Society of Molecular Imaging/Academy of Molecular Imaging joint c...

Rosetta Genomics Announces Initiation of In Vivo Studies Following Successful Completion of First Milestone in MicroRNA-based Therapeutic Program for Liver Cancer

Following the Screening and the Testing of Hundreds of MicroRNAs, Eight MicroRNAs Were Identified that Effectively Reduce Liver Cancer Cell Growth REHOVOT, Israel and NORTH BRUNSWICK, New Jersey, November 14 /PRNewswire-FirstCall/ -- Rosetta Genomics, Ltd. (NASDQ: ROSG) announced today the in...

VisEn Launches Next-Generation Fast ('Fluorescence Activatible Sensor Technology') Agent Platform for Expanded Performance in Imaging Disease Biomarkers In Vivo

MMPSense(TM) 750 FAST is Presented at AACR 100th Annual Meeting BEDFORD, Mass., April 20 /PRNewswire/ -- VisEn Medical Inc., a leader in fluorescence in vivo imaging from research through medicine, announced today the introduction of its new FAST ("Fluorescent Activatible Sensor Technolog...

Cequent Pharmaceuticals Meets Novartis Option Fund Milestone; Continues to Next Phase to Validate Inflammatory Bowel Disease Targets in Vivo

CAMBRIDGE, Mass., Sept. 15 /PRNewswire/ -- Cequent Pharmaceuticals, a pioneer in the development of novel products to deliver RNAi-based treatments to prevent and treat human disease, announced that it has met its second milestone in its option agreement with the Novartis Option Fund and will ...

Epeius Biotechnologies Awarded U.S. Patent for Targeted Injectable Gene Delivery In Vivo

SAN MARINO, Calif., March 25 /PRNewswire/ -- Epeius Biotechnologies Corporation announced today the issue of U.S. Patent No. 7,347,998 for Targeted Gene Delivery in vivo. This patent provides additional intellectual property protection for the platform of highly advanced biotechnologies embodi...

Kodak in vivo imaging system: precise coregistration of molecular imaging with anatomical X-ray imaging in animals

Kodak Molecular Imaging Systems introduces a line of small-animal in vivo imaging instruments that provide a new level of molecular signal localization in live animals. The Image Station In-Vivo FX allows precise multi-modal coregistration of optical or r...

Cytosolic expression of Green Fluorescent Protein (GFP) and its derivatives in the yeast Saccharomyces cerevisiae: Detection in vivo using the Varian Cary Eclipse

Cytosolic expression of Green Fluorescent Protein (GFP) and its derivatives in the yeast Saccharomyces cerevisiae : Detection in vivo using the Varian Cary Eclipse Paul Gavin# and Mark Prescott # , Ph.D Daren J. Fyfe, Ph.D * # Department of Bi...

Quantitative Analysis of Protein-DNA Associations in Vivo Using Real-Time PCR, Rev A

Swarup K Chakrabarti and Raghavendra G Mirmira*, Departments of Medicine and Pharmacology, Division of Endocrinology and Metabolism, University of Virginia Health Sciences Center, 450 Ray C Hunt Dr, Box 801407, Charlottesville, VA 22903 USA ...

In Vivo Signal Transduction Pathway Reporting Systems

New tools to study in vivo functions of new genes and drug candidates Li Xu * Tim Sanchez * ChaoFeng Zheng Stratagene Cloning Systems, Inc. Stratagene's PathDetect in vivo signal transduction pathway reporting systems are designed for specific, rapid and convenient assessment of ...

Assess the In Vivo Activation of Signal Transduction Pathways with PathDetect Reporting Systems

A review of products for signal transduction research Assess the In Vivo Activation of Signal Transduction Pathways with PathDetect Reporting Systems Li Xu Tim Sanchez Mary Buchanan Chao-Feng Zheng Stratagene Signal transduction is essential to many cellular pr...

NeurogesX Reports Second Quarter 2009 Results

...drugs of acetaminophen, have been evaluated in in vivo and in vitro preclinical studies and have demon... protectant, has been evaluated in vitro and in vivo . Equivalent dose levels of NGX-1576 in mice produ...atform, has been evaluated in proof of concept in vivo and in vitro preclinical studies for its potent...

NeurogesX Announces New PDUFA Date for Qutenza(TM) New Drug Application

...includes pre-clinical compounds, which are prodrugs of acetaminophen and various opioids. The company has evaluated these compounds in vitro and in vivo and is currently seeking development partners for these programs. Safe Harbor Statement This press release contains forward-l...

Shanghai ChemPartner and ELARA Pharmaceuticals Expand Drug Discovery Collaboration to a New Level

...any is developing a portfolio of highly-potent orally-available inhibitors of the hypoxia signalling pathway. The lead compound shows an excellent in vivo profile and is expected to move into formal preclinical development this year. Further information is available at http://www.elarapharma.com ...

Eiger BioPharmaceuticals Acquires Exclusive License to Novel Hepatitis C Virus (HCV) Technology From Stanford University

...ity against Hepatitis C, Hepatitis D, and other viruses. Eiger www.eige r bio.com investors include InterWest Partners www.interwest.com and vivo Ventures www.vivoventures.com . Contact: info@eigerbio.com 1-650-320-9900 ...

NeurogesX to Hold Conference Call to Discuss Second Quarter 2009 Financial Results

...includes pre-clinical compounds, which are prodrugs of acetaminophen and various opioids. The company has evaluated these compounds in vitro and in vivo and is currently seeking development partners for these programs. Safe Harbor Statement This press release contains forward-looking...

Cardium Announces New Orthobiologics Product Initiative Extending Gene Activated Matrix Technology to Deliver Bone Growth Factors

...one-grafting applications. Published data for periodontal tissue engineering include: (1) Platelet-Derived Growth Factor Gene Delivery Stimulates ex vivo Gingival Repair , (Anusaksathien, et al., Tissue Eng . 2003 August; 9(4): 745-756); (2) Engineering of Tooth-Supporting Structures by Delivery of PD...

Caliper Life Sciences Reports Second Quarter 2009 Results

...and diagnostic tests more quickly and efficiently. Caliper is aggressively innovating new technology to bridge the gap between in vitro assays and in vivo results and then translating those results into cures for human disease. Caliper's portfolio of offerings includes state-of-the-art microfluidics, la...

Sangamo BioSciences Reports Second Quarter 2009 Financial Results

...Foundation. The grant will support an innovative global health research project conducted by Sangamo scientists titled "Zinc Finger Nucleases for In vivo Treatment of HIV Infection." Promotion of Philip D. Gregory, D. Phil. to Chief Scientific Officer in addition to his role as Vice President, R...

Caliper Life Sciences' Second Quarter 2009 Financial Results Conference Call Notice

... and diagnostic tests more quickly and efficiently. Caliper is aggressively innovating new technology to bridge the gap between in vitro assays and in vivo results and then translating those results into cures for human disease. Caliper's portfolio of offerings includes state-of-the-art microfluidics, lab...

Champions Biotechnology Partners with Do-Coop Technologies to Advance Its Novel Oncology Compound Into Biomerk Tumorgraft(TM) Testing

...crotubule-Associated Protein Tau) deficient tumors. In both in vitro and in vivo models, SG410 has demonstrated promising activity against prostate and panc...by allowing researchers to use the same delivery system from in vitro to in vivo research, avoiding a key factor in late-stage failure. Biotech companies ca...

Oncolytics Biotech(R) Inc. Research Collaborators Present Glioma Reovirus Research at ASV Annual Meeting

...lyses revealed moderate to strong synergy in primary patient glioma cells treated with reovirus plus IR and TMZ in vitro. This effect was also seen in vivo in flank tumor xenografts from primary patient tumors resistant to reovirus therapy alone. The investigators concluded that the data supports the us...

BioWa Announces License of POTELLIGENT(R) Technology to Merck KGaA

...NT((R)) Technology dramatically enhances ADCC activity of an antibody in vitro , and significantly increases potency and efficacy of the antibody in vivo . A number of POTELLIGENT((R)) antibodies are being investigated in human clinical trials. About BioWa, Inc. BioWa is a wholly owned s...

Shanghai ChemPartner and Agios Expand Integrated Drug Discovery Research Collaboration

...field of cancer metabolism. ChemPartner will provide integrated services in the areas of protein science, HTS, in vitro enzyme assay, cell biology, in vivo pharmacology, etc., for Agios' innovative R&D program to discover novel clinical candidates for oncology indications. Michael Hui, founder ...

VisEn Launches New Cat-K FAST(TM) Fluorescence Molecular Imaging Agent

...- VisEn Medical Inc., a leader in fluorescence in vivo imaging from research through medicine, announced...h disease progression and therapeutic response in vivo . Cathepsin K expression is well known as a key b... ("Fluorescent Activatable Sensor Technology") in vivo agent platform. FAST agents are based on high-...

AEterna Zentaris: New Data Published on its Ghrelin Antagonist Compound, AEZS-123 (JMV2959), Supports its Use in Alcohol Addiction

...the chemical synthesis and pharmacological investigation of new compounds acting as ghrelin antagonists. In 2006, AEterna Zentaris reported first in vivo pharmacological data on the capability of proprietary ghrelin receptor antagonists to selectively inhibit food intake. At the annual meetings of the...

Caliper Life Sciences Introduces Staccato Protein Workstation for Automated Protein Sample Preparation & Analysis

... and diagnostic tests more quickly and efficiently. Caliper is aggressively innovating new technology to bridge the gap between in vitro assays and in vivo results and then translating those results into cures for human disease. Caliper's portfolio of offerings includes state-of-the-art microfluidics, lab...

NeurogesX Added to Russell 3000 Index

...includes pre-clinical compounds, which are prodrugs of acetaminophen and various opioids. The company has evaluated these compounds in vitro and in vivo and is currently seeking development partners for these programs. Safe Harbor Statement This press release contains forward-looki...

World Nanomedicine Market to Cross $160 Billion by 2015, According to New Report by Global Industry Analysts, Inc.

...strategic industry activities. The study analyzes the nanomedicine market by the following application areas - Drug Delivery, In Vitro Diagnostics, In vivo Imaging, Biomaterials and Other Applications. For more details about this comprehensive market research report, please visit - http://www.strateg...

Rules-Based Medicine, Inc. Launches DiscoveryMAP(TM) Service for Drug and Diagnostic Development

... for hundreds of proteins cost-effectively in multiple species, and from a small sample volume. The Company also offers innovative and proprietary ex vivo testing systems such as TruCulture(TM), the first fully-closed, reproducible whole blood culture system. RBM is actively developing multiplex diagnos...

Cynvec to Present at The 2009 New York Venture Summit

...me cancer diagnostic. Cynvec expects to begin Phase I clinical trials of CYN 101 in the third quarter of 2009. The sindbis vector has demonstrated in vivo efficacy delivering a variety of cytokines directly to tumor sites. Additionally, a screening program is underway to identify small molecules that bi...

NeurogesX Provides U.S. Regulatory Update for Qutenza(TM)

...includes pre-clinical compounds, which are prodrugs of acetaminophen and various opioids. The company has evaluated these compounds in vitro and in vivo and is currently seeking development partners for these programs. Safe Harbor Statement This press release contains forward-looki...

Caliper Life Sciences to Webcast Investor Session of Open House

... and diagnostic tests more quickly and efficiently. Caliper is aggressively innovating new technology to bridge the gap between in vitro assays and in vivo results and then translating those results into cures for human disease. Caliper's portfolio of offerings includes state-of-the-art microfluidics, lab...

Celator(R) Pharmaceuticals Presents Data on the Activity of CPX-351 Against Leukemia at the European Hematology Association Congress

... comparing the sensitivity of various blood cell types to CPX-351 and evaluating the uptake of CPX-351 by human leukemia cells both in vitro and in vivo (mouse xenograft models).(2) They reported that CPX-351 ablated leukemic cells but permitted the regrowth of normal bone marrow cells within 42 days ...